The whole-of-society approach of mass COVID-19 vaccination in China: a qualitative study

Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's...

Full description

Saved in:
Bibliographic Details
Published inHealth research policy and systems Vol. 20; no. 1; p. 142
Main Authors Wang, Qian, Qu, Zhiqiang, Tu, Shiyi, Chen, Xi, Hou, Zhiyuan
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 30.12.2022
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks-leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries.
AbstractList Abstract Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China’s COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. Methods We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks—leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. Results A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Conclusions Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries.
Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks--leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries.
Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks-leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries.
Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. Methods We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks--leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. Results A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Conclusions Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries. Keywords: COVID-19 vaccine, Mass vaccination, Vaccination system, Whole-of-society, Qualitative study, Interview
BACKGROUNDMany countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. METHODSWe conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks-leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. RESULTSA total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. CONCLUSIONSOur study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries.
Abstract Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China’s COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. Methods We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks—leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. Results A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Conclusions Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries.
ArticleNumber 142
Audience Academic
Author Hou, Zhiyuan
Chen, Xi
Wang, Qian
Tu, Shiyi
Qu, Zhiqiang
Author_xml – sequence: 1
  givenname: Qian
  surname: Wang
  fullname: Wang, Qian
  organization: NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China
– sequence: 2
  givenname: Zhiqiang
  surname: Qu
  fullname: Qu, Zhiqiang
  organization: NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China
– sequence: 3
  givenname: Shiyi
  surname: Tu
  fullname: Tu, Shiyi
  organization: NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China
– sequence: 4
  givenname: Xi
  surname: Chen
  fullname: Chen, Xi
  organization: Department of Economics, Yale University, City of New Haven, United States of America
– sequence: 5
  givenname: Zhiyuan
  orcidid: 0000-0003-3413-0076
  surname: Hou
  fullname: Hou, Zhiyuan
  email: zyhou@fudan.edu.cn, zyhou@fudan.edu.cn
  organization: NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China. zyhou@fudan.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36585666$$D View this record in MEDLINE/PubMed
BookMark eNptkttrFDEUxgep2Iv-Az5IwBd9mJr7xQehrLeFQkGr-BbOZpKdlNnJdjKzuv-92W4tXZA8JOfk933khO-0OupT76vqJcHnhGj5LhNqJKkxpTXGhqtaPalOCFe65gKLo0fn4-o05xtcSMPos-qYSaGFlPKk-nXdevS7TZ2vU6hzctGPWwTr9ZDAtSgFtIKc0ezq5_xjTQzagHOxhzGmHsUezdpSvEeAbifo4lj6G4_yODXb59XTAF32L-73s-rH50_Xs6_15dWX-ezisnZCmrEGrkxgVBrwQIwoZVDEUeGDgEYH8BozA0ooR5wsQ0qlG7yQhHJJnPPAzqr53rdJcGPXQ1zBsLUJor1rpGFpYRij67xloaGSgQTlHAcfDNeSL6hmjgnNm53Xh73XelqsfON8Pw7QHZge3vSxtcu0sUZjiikrBm_uDYZ0O_k82lXMzncd9D5N2VIljBFKYF7Q13t0CeVpsQ-pOLodbi8UI5oKwXGhzv9DldX4VXQlDiGW_oHg7YGgMKP_My5hytnOv387ZOmedUPKefDhYVKC7S5hdp8wW3Jj7xJmVRG9evxHD5J_kWJ_Aa24y08
CitedBy_id crossref_primary_10_2139_ssrn_4819526
Cites_doi 10.1007/s11366-020-09711-6
10.3390/vaccines9101071
10.1186/s43058-021-00184-z
10.1016/S0140-6736(21)00306-8
10.2196/27632
10.1016/j.jiph.2019.12.009
10.1016/S0140-6736(20)32642-8
10.2471/BLT.21.285616
10.1080/0142159X.2020.1755030
10.3389/fpubh.2021.756677
10.1001/jama.2020.8917
10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4
10.1111/nyas.12503
10.1186/s13584-021-00481-x
10.1016/j.vaccine.2022.01.059
10.1038/s41591-021-01454-y
10.1001/jama.2020.8711
10.3390/vaccines9050476
10.1038/s41577-021-00531-0
10.1016/S0140-6736(21)00617-6
10.1101/2021.07.23.21261013
10.3389/fpubh.2021.709127
10.1016/j.bjoms.2020.05.009
10.2147/RMHP.S338701
10.1186/s13584-021-00440-6
10.1186/s13584-021-00441-5
10.1007/s11366-012-9204-4
10.46234/ccdcw2021.157
10.46234/ccdcw2022.173
10.1080/14760584.2019.1574224
10.1080/10810730.2021.1884773
10.1186/s13584-021-00449-x
10.3390/vaccines9111329
10.4161/21645515.2014.969618
10.1016/j.jad.2020.08.059
ContentType Journal Article
Copyright 2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
The Author(s) 2022
Copyright_xml – notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: The Author(s) 2022
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ISR
7X8
5PM
DOA
DOI 10.1186/s12961-022-00947-7
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE

MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1478-4505
EndPage 142
ExternalDocumentID oai_doaj_org_article_3fd263a6a7cc4aef94864b283c3584da
A731825540
10_1186_s12961_022_00947_7
36585666
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: K01 AG053408
GroupedDBID ---
-A0
0-V
0R~
29I
2WC
3V.
44B
53G
5VS
7X7
7XC
88E
8C1
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACHQT
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALSLI
AMKLP
AMTXH
AOIJS
AQUVI
ARALO
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DPSOV
DU5
DWQXO
E3Z
EBD
EBLON
EBS
ECM
EIF
ESX
FAC
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ISR
ITC
KC-
KQ8
M0T
M1P
M2L
M~E
NPM
O5R
O5S
OK1
P2P
PATMY
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PYCSY
PZZ
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
UNMZH
W2D
WOQ
WOW
XSB
~8M
AAYXX
CITATION
ABVAZ
AFGXO
AFNRJ
7X8
5PM
ID FETCH-LOGICAL-c569t-a479f3269aea195a47f71c25ef5ad8fae8039a757c1c6094678d0b612461ccea3
IEDL.DBID RPM
ISSN 1478-4505
IngestDate Tue Oct 22 14:53:57 EDT 2024
Tue Sep 17 21:30:36 EDT 2024
Fri Oct 25 04:27:21 EDT 2024
Thu Feb 22 23:41:30 EST 2024
Fri Feb 02 04:24:48 EST 2024
Sat Sep 28 21:38:35 EDT 2024
Thu Sep 12 17:39:40 EDT 2024
Sat Sep 28 08:17:34 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19 vaccine
Whole-of-society
Qualitative study
Vaccination system
Mass vaccination
Interview
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c569t-a479f3269aea195a47f71c25ef5ad8fae8039a757c1c6094678d0b612461ccea3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3413-0076
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802023/
PMID 36585666
PQID 2759957504
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_3fd263a6a7cc4aef94864b283c3584da
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9802023
proquest_miscellaneous_2759957504
gale_infotracmisc_A731825540
gale_infotracacademiconefile_A731825540
gale_incontextgauss_ISR_A731825540
crossref_primary_10_1186_s12961_022_00947_7
pubmed_primary_36585666
PublicationCentury 2000
PublicationDate 2022-12-30
PublicationDateYYYYMMDD 2022-12-30
PublicationDate_xml – month: 12
  year: 2022
  text: 2022-12-30
  day: 30
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Health research policy and systems
PublicationTitleAlternate Health Res Policy Syst
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References J Schwartz (947_CR31) 2012; 17
GP Marchildon (947_CR15) 2021; 10
X Zhang (947_CR29) 2021; 26
B Trogen (947_CR4) 2020; 323
OJ Wouters (947_CR1) 2021; 397
JG Head (947_CR20) 1969; 28
947_CR22
Y Zhou (947_CR44) 2020; 277
Z Meng (947_CR39) 2021; 14
D Gong (947_CR45) 2021; 9
M Mckee (947_CR16) 2021; 10
JS Solís Arce (947_CR36) 2021; 27
947_CR24
RA Burgess (947_CR41) 2021; 397
F Oliani (947_CR13) 2022; 40
NA Addy (947_CR27) 2014; 1331
947_CR8
A Guignard (947_CR11) 2019; 18
D Levin-Zamir (947_CR33) 2020; 25
HJ Larson (947_CR37) 2015
KR Nehal (947_CR7) 2021; 9
S Shilo (947_CR35) 2021; 21
ME Kiger (947_CR21) 2020; 42
J Gao (947_CR30) 2021; 9
HJ Larson (947_CR43) 2014; 10
947_CR19
947_CR18
947_CR17
ET Tagoe (947_CR9) 2021; 9
Z Hou (947_CR6) 2021; 23
Y Qian (947_CR38) 2021; 3
H Liu (947_CR23) 2021
NP Sobers (947_CR25) 2021; 2
L The (947_CR2) 2021; 397
947_CR10
947_CR32
S Schaffer DeRoo (947_CR5) 2020; 323
L Gong (947_CR40) 2021; 9
B Rosen (947_CR12) 2021; 10
947_CR14
S Zang (947_CR42) 2022; 4
B Rosen (947_CR34) 2021; 10
AA Hyder (947_CR3) 2021; 99
SS Dubb (947_CR26) 2020; 58
I Wignjadiputro (947_CR28) 2020; 13
References_xml – ident: 947_CR10
– volume: 26
  start-page: 189
  issue: 1
  year: 2021
  ident: 947_CR29
  publication-title: J Chin Polit Sci
  doi: 10.1007/s11366-020-09711-6
  contributor:
    fullname: X Zhang
– volume: 9
  start-page: 1071
  issue: 10
  year: 2021
  ident: 947_CR7
  publication-title: Vaccines
  doi: 10.3390/vaccines9101071
  contributor:
    fullname: KR Nehal
– volume: 2
  start-page: 79
  issue: 1
  year: 2021
  ident: 947_CR25
  publication-title: Implement Sci Commun
  doi: 10.1186/s43058-021-00184-z
  contributor:
    fullname: NP Sobers
– volume: 397
  start-page: 1023
  issue: 10278
  year: 2021
  ident: 947_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00306-8
  contributor:
    fullname: OJ Wouters
– volume: 23
  issue: 6
  year: 2021
  ident: 947_CR6
  publication-title: J Med Internet Res
  doi: 10.2196/27632
  contributor:
    fullname: Z Hou
– volume: 13
  start-page: 994
  issue: 7
  year: 2020
  ident: 947_CR28
  publication-title: J Infect Public Health
  doi: 10.1016/j.jiph.2019.12.009
  contributor:
    fullname: I Wignjadiputro
– ident: 947_CR14
– volume: 397
  start-page: 8
  issue: 10268
  year: 2021
  ident: 947_CR41
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)32642-8
  contributor:
    fullname: RA Burgess
– volume: 28
  start-page: 214
  issue: 2
  year: 1969
  ident: 947_CR20
  publication-title: FinanzArchiv Public Finance Anal
  contributor:
    fullname: JG Head
– volume: 99
  start-page: 406-A
  issue: 6
  year: 2021
  ident: 947_CR3
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.21.285616
  contributor:
    fullname: AA Hyder
– volume: 42
  start-page: 846
  issue: 8
  year: 2020
  ident: 947_CR21
  publication-title: Med Teach
  doi: 10.1080/0142159X.2020.1755030
  contributor:
    fullname: ME Kiger
– volume: 9
  year: 2021
  ident: 947_CR30
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2021.756677
  contributor:
    fullname: J Gao
– volume: 323
  start-page: 2460
  issue: 24
  year: 2020
  ident: 947_CR4
  publication-title: JAMA
  doi: 10.1001/jama.2020.8917
  contributor:
    fullname: B Trogen
– year: 2015
  ident: 947_CR37
  publication-title: PLoS Curr
  doi: 10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4
  contributor:
    fullname: HJ Larson
– volume: 1331
  start-page: 216
  year: 2014
  ident: 947_CR27
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/nyas.12503
  contributor:
    fullname: NA Addy
– ident: 947_CR19
– volume: 10
  start-page: 43
  issue: 1
  year: 2021
  ident: 947_CR34
  publication-title: Israel J Health Policy Res
  doi: 10.1186/s13584-021-00481-x
  contributor:
    fullname: B Rosen
– volume: 40
  start-page: 1397
  issue: 10
  year: 2022
  ident: 947_CR13
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2022.01.059
  contributor:
    fullname: F Oliani
– volume: 27
  start-page: 1385
  issue: 8
  year: 2021
  ident: 947_CR36
  publication-title: Nat Med
  doi: 10.1038/s41591-021-01454-y
  contributor:
    fullname: JS Solís Arce
– volume: 323
  start-page: 2458
  issue: 24
  year: 2020
  ident: 947_CR5
  publication-title: JAMA
  doi: 10.1001/jama.2020.8711
  contributor:
    fullname: S Schaffer DeRoo
– volume: 9
  start-page: 476
  issue: 5
  year: 2021
  ident: 947_CR45
  publication-title: Vaccines
  doi: 10.3390/vaccines9050476
  contributor:
    fullname: D Gong
– volume: 21
  start-page: 198
  issue: 4
  year: 2021
  ident: 947_CR35
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-021-00531-0
  contributor:
    fullname: S Shilo
– volume: 397
  start-page: 941
  issue: 10278
  year: 2021
  ident: 947_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00617-6
  contributor:
    fullname: L The
– year: 2021
  ident: 947_CR23
  publication-title: medRxiv
  doi: 10.1101/2021.07.23.21261013
  contributor:
    fullname: H Liu
– ident: 947_CR32
– ident: 947_CR8
– volume: 9
  year: 2021
  ident: 947_CR9
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2021.709127
  contributor:
    fullname: ET Tagoe
– volume: 58
  start-page: 838
  issue: 7
  year: 2020
  ident: 947_CR26
  publication-title: Br J Oral Maxillofac Surg
  doi: 10.1016/j.bjoms.2020.05.009
  contributor:
    fullname: SS Dubb
– volume: 14
  start-page: 4649
  year: 2021
  ident: 947_CR39
  publication-title: Risk Manag Healthc Policy
  doi: 10.2147/RMHP.S338701
  contributor:
    fullname: Z Meng
– volume: 10
  start-page: 6
  issue: 1
  year: 2021
  ident: 947_CR12
  publication-title: Isr J Health Policy Res
  doi: 10.1186/s13584-021-00440-6
  contributor:
    fullname: B Rosen
– ident: 947_CR17
– volume: 10
  start-page: 5
  issue: 1
  year: 2021
  ident: 947_CR16
  publication-title: Isr J Health Policy Res
  doi: 10.1186/s13584-021-00441-5
  contributor:
    fullname: M Mckee
– volume: 17
  start-page: 313
  issue: 3
  year: 2012
  ident: 947_CR31
  publication-title: J Chin Polit Sci
  doi: 10.1007/s11366-012-9204-4
  contributor:
    fullname: J Schwartz
– volume: 3
  start-page: 645
  issue: 30
  year: 2021
  ident: 947_CR38
  publication-title: China CDC Wkly
  doi: 10.46234/ccdcw2021.157
  contributor:
    fullname: Y Qian
– ident: 947_CR22
– ident: 947_CR18
– volume: 4
  start-page: 832
  issue: 37
  year: 2022
  ident: 947_CR42
  publication-title: China CDC Wkly
  doi: 10.46234/ccdcw2022.173
  contributor:
    fullname: S Zang
– volume: 18
  start-page: 119
  issue: 2
  year: 2019
  ident: 947_CR11
  publication-title: Expert Rev Vaccines
  doi: 10.1080/14760584.2019.1574224
  contributor:
    fullname: A Guignard
– ident: 947_CR24
– volume: 25
  start-page: 816
  issue: 10
  year: 2020
  ident: 947_CR33
  publication-title: J Health Commun
  doi: 10.1080/10810730.2021.1884773
  contributor:
    fullname: D Levin-Zamir
– volume: 10
  start-page: 12
  issue: 1
  year: 2021
  ident: 947_CR15
  publication-title: Isr J Health Policy Res
  doi: 10.1186/s13584-021-00449-x
  contributor:
    fullname: GP Marchildon
– volume: 9
  start-page: 1329
  issue: 11
  year: 2021
  ident: 947_CR40
  publication-title: Vaccines
  doi: 10.3390/vaccines9111329
  contributor:
    fullname: L Gong
– volume: 10
  start-page: 2543
  issue: 9
  year: 2014
  ident: 947_CR43
  publication-title: Hum Vaccines Immunother
  doi: 10.4161/21645515.2014.969618
  contributor:
    fullname: HJ Larson
– volume: 277
  start-page: 510
  year: 2020
  ident: 947_CR44
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2020.08.059
  contributor:
    fullname: Y Zhou
SSID ssj0022932
Score 2.3599086
Snippet Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination...
Abstract Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize...
Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19...
BACKGROUNDMany countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19...
Abstract Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 142
SubjectTerms Aged
Analysis
China
COVID-19 - prevention & control
COVID-19 vaccine
COVID-19 Vaccines
Epidemics
Humans
Interview
Mass vaccination
Pandemics
Qualitative study
Vaccination
Vaccination system
Vaccines
Whole-of-society
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT5UQ4k2gVAYhcUBW8_Aj5tYWqhYJkICivVljx4Y9kCCyW_4-YzupNuLAhWPiOcQzY8830cw3hLywVahaKSqGoUCw6CEMIDTMonvpDiEp6Njv_P6DPL_k71ZitTPqK9aEZXrgrLijJnS1bECCco6DD5q3klsMiq7B2NllaFTqOZmaUi0MYvXcItPKoxGjmsS0GROvWEqnmFqEocTW__edvBOUlgWTOxHo7Da5NUFHepw_-Q654fu75Gb-70ZzO9E9skK7099x6C0bAhtzTSadmcPpEOgPhMv09OPXizes0vQKnFvnP4J03dM0Tvs1BZqbLRMrOE0UtPfJ5dnbL6fnbJqewJyQesOAKx0QnGnwUGmBj0FVrhY-COjaAL4tGw1KKFc5iUrBqNWVFgEPl5VzHpoHZK8fev-IUAtcQiU8tKrjKGuF4421HKGN67SvC_JqVqb5mUkyTEouWmmy6g2q3iTVG1WQk6jva8lIcJ1eoNnNZHbzL7MX5Hm0lokUFn2skfkG23E0F58_mWOF9xRmSrwsyMtJKAxoNwdTywHuKrJeLSQPFpJ4xtxi-dnsFCYuxcK03g_b0dQqMrZFjvyCPMxOcr2xBtEdomVZELVwn8XOlyv9-nui-NZtGefaP_4fqnpC9uvo-ZGdsjwge5tfW_8UkdTGHqZD8wdPZxlQ
  priority: 102
  providerName: Directory of Open Access Journals
Title The whole-of-society approach of mass COVID-19 vaccination in China: a qualitative study
URI https://www.ncbi.nlm.nih.gov/pubmed/36585666
https://search.proquest.com/docview/2759957504
https://pubmed.ncbi.nlm.nih.gov/PMC9802023
https://doaj.org/article/3fd263a6a7cc4aef94864b283c3584da
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELa28YKEEL8XGJVBSDwgr03iHzFva9m0IW1Mg6GKF-vi2KMSTaa1hX-fs5NMi3jjJVLrq1SfP-e-s-4-E_KuTH1aSJEyDAWCBYQwAJ-zEuGlK6SkoEO_8-mZPL7kn-divkVE3wsTi_Ztudivfy3368XPWFt5vbTjvk5sfH4608Uk3Po93ibbCNA-Re-yLIxfWd8dU8jxCgOaxIwZc65QRaeYGkSgKNT_7-v4Tjwa1kreCT5Hj8jDjjXSg_bfPSZbrn5CHrRHbrTtJHpK5rjk9E-475Y1nq3ackzai4bTxtMlMmU6-_L95BNLNf0N1i7aw0C6qGm8SfsjBdr2WUZBcBrVZ5-Ry6PDb7Nj1l2cwKyQes2AK-2Rl2lwkGqBH71KbSacF1AVHlwxyTUooWxqJToFA1Y1KZHrcJla6yB_Tnbqpna7hJbAJaTCQaEqjralsDwvS46sxlbaZQn50DvTXLf6GCbmFYU0resNut5E1xuVkGnw961l0LaOXzQ3V6ZbYZP7KpM5SFDWcnBe80LyEmmQzZEtVZCQt2G1TFCvqEN5zBVsVitz8vXCHCh8RWGSxCcJed8Z-QbXzULXbYCzCoJXA8u9gSVuLzsYftODwoShUJNWu2azMpkKYm1BHj8hL1qQ3E4sR2KHRFkmRA3gM5j5cATBHtW9O3C__O9fviL3swD3oEY52SM765uNe43MaV2OcL_MFT6LWToi96aHZ-cXo3gKgc-L6Y9R3El_AV2OHM8
link.rule.ids 230,315,730,783,787,867,888,2109,27936,27937,31732,33279,33757,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOYCEeD8CBQxC4oC8m4cfCbeyUO1CtyBoq71ZtmOXFWxSNbsg8esZO0nVwAmOiSdSnPmc-caa-YzQC524JOcsIRAKGPEIIUq5jGiAV1ECJVWF73eeH_DpEX2_YIstxPpemFC0b_RyVH1fjarl11Bbeboy475ObPxpPiny2J_6Pb6ELsN6jWmfpHd5FkSwtO-Pyfm4gZDGIWeGrMvX0QkiBjEoSPX__UO-EJGG1ZIXws_eDXTcv3hbdfJttFnrkfn1h6bjP8_sJrreEVK82w7fQlu2uo2utbt5uG1SuoMWgCb80x-lS2pHmrbSE_d65Lh2eAUkHE8-Hs_ekqTAP5Qxy3afES8rHA7pfo0Vbls4g9Y4DsK2d9HR3rvDyZR0ZzIQw3ixJoqKwgHlK5RVScHg0onEpMw6psrcKZvHWaEEEyYxHL42xMIy1kCjKE-MsSq7h7arurIPENaKcpUwq3JRUrDVzNBMawqEyZSFTSP0qveSPG2lN2RIWXIuW59K8KkMPpUiQm-8I88tvWx2uFGfncjuE8vMlSnPFFfCGKqsK2jOqQaGZTIgYqWK0HMPA-mFMSpfeXOiNk0jZ18-y10Bfz_Iv2gcoZedkasBEEZ1jQwwK6-lNbDcGVjCyjWD4Wc92qQf8uVula03jUyF14HzyvsRut-i73xiGXBG4OA8QmKAy8HMhyOAtiAc3qHr4X8_-RRdmR7O9-X-7ODDI3Q19WvKi17GO2h7fbaxj4GgrfWTsBx_A7UtOWs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELZgSAgJ8RsWGGAQEg_IbX44dszb6KhWYGMCNlW8WLZjbxU0qdYWJP56zk4yNfC2x9RXKc59zn0X3X2H0CuduKRgeUIgFOTEI4Qo5TKiAV6iBEqqhO93Pjhk-8f0wzSfboz6CkX7Rs8G1c_5oJqdhdrKxdwMuzqx4dHBSBSxn_o9XJRueBVdgzMbsy5Rb3MtiGJp1yNTsOESwhqDvBkyL19LxwnvxaEg1___S3kjKvUrJjdC0Pg2-t7dfFN58mOwXumB-fOPruOldncH3WqJKd5tTO6iK7a6h242X_Vw06x0H00BVfi3H6lLakeWTcUn7nTJce3wHMg4Hn0-meyRROBfyphZ870RzyochnW_xQo3rZxBcxwHgdsH6Hj8_tton7SzGYjJmVgRRblwQP2EsioROVw6npg0ty5XZeGULeJMKJ5zkxgGTxxiYhlroFOUJcZYlT1EW1Vd2W2EtaJMJblVBS8p2Orc0ExrCsTJlMKmEXrTeUouGgkOGVKXgsnGrxL8KoNfJY_QO-_MC0svnx1-qM9PZfuYZebKlGWKKW4MVdYJWjCqgWmZDAhZqSL00kNBeoGMylfgnKr1ciknX7_IXQ5vQcjDaByh162RqwEURrUNDbArr6nVs9zpWcIJNr3lFx3ipF_yZW-VrddLmXKvB-cV-CP0qEHgxcYy4I7AxVmEeA-bvZ33VwBxQUC8RdjjS__zObp-tDeWnyaHH5-gG6k_Vl77Mt5BW6vztX0KPG2ln4UT-ReC9Tvr
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+whole-of-society+approach+of+mass+COVID-19+vaccination+in+China%3A+a+qualitative+study&rft.jtitle=Health+research+policy+and+systems&rft.au=Wang%2C+Qian&rft.au=Qu%2C+Zhiqiang&rft.au=Tu%2C+Shiyi&rft.au=Chen%2C+Xi&rft.date=2022-12-30&rft.pub=BioMed+Central+Ltd&rft.issn=1478-4505&rft.eissn=1478-4505&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12961-022-00947-7&rft.externalDBID=ISR&rft.externalDocID=A731825540
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-4505&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-4505&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-4505&client=summon